These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
152 related items for PubMed ID: 8678706
1. The Physicians' Desk Reference. Problems and possible improvements. Cohen JS, Insel PA. Arch Intern Med; 1996 Jul 08; 156(13):1375-80. PubMed ID: 8678706 [Abstract] [Full Text] [Related]
2. Editorial: limitations of the physicians' desk reference 2007. Mindel JS, Teich SA, Teich CM, Beam P. Surv Ophthalmol; 2008 Jul 08; 53(1):82-4. PubMed ID: 18191659 [No Abstract] [Full Text] [Related]
3. Lessons learned from independent central review. Ford R, Schwartz L, Dancey J, Dodd LE, Eisenhauer EA, Gwyther S, Rubinstein L, Sargent D, Shankar L, Therasse P, Verweij J. Eur J Cancer; 2009 Jan 08; 45(2):268-74. PubMed ID: 19101138 [Abstract] [Full Text] [Related]
4. A literature search on pharmacokinetic drug interactions of statins and analysis of how such interactions are reflected in package inserts in Japan. Saito M, Hirata-Koizumi M, Urano T, Miyake S, Hasegawa R. J Clin Pharm Ther; 2005 Feb 08; 30(1):21-37. PubMed ID: 15659001 [Abstract] [Full Text] [Related]
5. Risk management strategies in the Physicians' Desk Reference product labels for pregnancy category X drugs. Uhl K, Kennedy DL, Kweder SL. Drug Saf; 2002 Feb 08; 25(12):885-92. PubMed ID: 12241129 [Abstract] [Full Text] [Related]
6. Incorrect or unsubstantiated indications listed for selected antimicrobials in the Physicians' Desk Reference. Rybak MJ, Gleckman R. Am J Hosp Pharm; 1979 Jun 08; 36(6):738. PubMed ID: 463882 [No Abstract] [Full Text] [Related]
8. The diminishing value of the Physicians' Desk Reference and drug package inserts as a medical and legal standard of medical usage of pharmaceutical drugs. Burkhart CG. J Drugs Dermatol; 2005 Jun 08; 4(4):414-5. PubMed ID: 16004013 [No Abstract] [Full Text] [Related]
9. Physicians' perceptions and uses of commercial drug information sources: an examination of pharmaceutical marketing to physicians. Spiller LD, Wymer WW. Health Mark Q; 2001 Jun 08; 19(1):91-106. PubMed ID: 11727295 [Abstract] [Full Text] [Related]
11. What is prescription labeling communicating to doctors about hepatotoxic drugs? A study of FDA approved product labeling. Willy ME, Li Z. Pharmacoepidemiol Drug Saf; 2004 Apr 08; 13(4):201-6. PubMed ID: 15255086 [Abstract] [Full Text] [Related]
12. Pharmacogenomic biomarker information in drug labels approved by the United States food and drug administration: prevalence of related drug use. Frueh FW, Amur S, Mummaneni P, Epstein RS, Aubert RE, DeLuca TM, Verbrugge RR, Burckart GJ, Lesko LJ. Pharmacotherapy; 2008 Aug 08; 28(8):992-8. PubMed ID: 18657016 [Abstract] [Full Text] [Related]
13. Providing drug information to health professionals and consumers: role and responsibility of the pharmaceutical manufacturer. Boyland JI. Hosp Pharm; 1983 Apr 08; 18(4):211-3, 216. PubMed ID: 10260207 [Abstract] [Full Text] [Related]
14. Setting the record straight on PDR criticisms. Mehta M. Postgrad Med; 2000 Jan 08; 107(1):22. PubMed ID: 10649658 [No Abstract] [Full Text] [Related]
15. A population-based study of the prevalence and influence of gifts to radiation oncologists from pharmaceutical companies and medical equipment manufacturers. Halperin EC, Hutchison P, Barrier RC. Int J Radiat Oncol Biol Phys; 2004 Aug 01; 59(5):1477-83. PubMed ID: 15275735 [Abstract] [Full Text] [Related]
19. FDA publishes conflict of interest rules for clinical trials. Food and Drug Administration. James JS. AIDS Treat News; 1998 Mar 06; (No 290):8. PubMed ID: 11365123 [Abstract] [Full Text] [Related]